This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Forschungsverbund Berlin E.v., Universität Zu Koln. Active years: 2025.
Company Filing History:
1 out of 93 
1 out of 28 
Years Active: 2025
Title: Dominik Albat: Innovator in Chemical Compounds
Introduction
Dominik Albat is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of chemical compounds, particularly in the development of structural mimetics of proline-rich peptides. His work has implications for pharmaceutical applications, especially in the treatment of tumor diseases.
Latest Patents
Dominik Albat holds a patent for "Polyproline mimetics of proline-derived module-15." This invention relates to chemical compounds that can selectively inhibit Ena/VASP-EVH1-mediated protein-protein interactions. The compounds are designed to serve as pharmaceutical agents, offering potential treatments for various tumor diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Albat has worked with prestigious institutions such as Universität zu Köln and Forschungsverbund Berlin e.V. His research has focused on innovative solutions in the realm of chemical compounds, contributing to advancements in medical science.
Collaborations
Dominik Albat has collaborated with esteemed colleagues, including Stephan Dohmen and Hans-Günther Schmalz. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Dominik Albat is a prominent figure in the field of chemical innovations, with a focus on developing compounds that have significant pharmaceutical potential. His contributions continue to influence the landscape of medical treatments for tumor diseases.